AustraliaÚltimas notícias

Telix Pharmaceuticals (ASX:TLX) submitted a Marketing Authorisation Application in Europe for its glioma imaging candidate, TLX101-Px.

Clinical-stage drug development company Nyrada (ASX:NYR) has released its half-year results for the 2026 fiscal year.

The Northern Territory Government has launched a major international recruitment drive for gas exploration, unveiling a massive new acreage release in the Beetaloo Basin.

Sports Entertainment Group (ASX:SEG) booked an underlying EBITDA of $9.7 million in H1 FY26, representing a 94% organic growth a year earlier.

Catalyst Metals (ASX:CYL) entered into a definitive agreement to purchase a substantial package of Bryah Basin exploration tenements from Albright Metals (ASX:ABR).

SHAPE Australia (ASX:SHA) reported revenue of $553.3 million for H1 FY26, a 16% increase compared to the prior corresponding period.

IDT Australia (ASX:IDT) reported a narrowing of its losses for the half-year ended Dec. 31, 2025.

Lycopodium (ASX:LYL) recorded revenue of $174.5 million and an EBITDA of $29.6 million for H1 FY26, resulting in a net profit after tax of $18.3 million.

Chrysos (ASX:C79) announced a record-breaking financial performance for the first half of FY26, driven by an unprecedented surge in gold sample volumes.

Solvar (ASX:SVR) reported a normalised net profit after tax of $20 million in the first half of FY26, representing a steady 5.8% increase.

Capstone Copper (ASX:CSC) outlined a strategic roadmap defined by steady production targets and significant capital investment in its development pipeline.

Marimaca Copper (ASX:MC2) announced a global offering totaling approximately CAD$409 million.